This inventor holds 3 USPTO granted patents. Top assignees: Osaka University, Other. Active years: 2002-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,044 
1 out of 834,570 Years Active: 2002-2015
Title: Shuji Miyagawa: Innovator in Chimeric Molecules and Recombinase Genes
Introduction
Shuji Miyagawa is a prominent inventor based in Ashiya, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric molecules and modified genes for mammals. With a total of 3 patents, his work has the potential to impact various applications in medical and biological research.
Latest Patents
Miyagawa's latest patents include innovative advancements in HLA-E chimeric molecules. These molecules are designed to provide nonhuman mammalian cells with resistance to cytotoxic human NK cells. The patents disclose nucleotide sequences encoding these chimeric molecules, as well as the nonhuman mammalian cells and mammals transformed with such sequences. The HLA-E chimeric molecules contain a peptide that reforms all or part of the signal peptide region, α1 domain, and/or α2 domain of HLA-E. Additionally, a transformant incorporating a nucleotide sequence of the invention expresses HLA-E efficiently.
Another significant patent involves a modified CRE recombinase gene for mammals. The objective of this invention is to provide a modified gene that exhibits expression levels in mammalian cells, tissues, organs, or bodies that are several times higher than that of phage-derived Cre recombinase. This is achieved by utilizing codons that are frequently used in mammalian cells.
Career Highlights
Miyagawa has worked with notable institutions, including Osaka University, where he has contributed to various research projects. His expertise in biotechnology and genetics has positioned him as a valuable asset in the scientific community.
Collaborations
Throughout his career, Miyagawa has collaborated with esteemed colleagues such as Katsuyoshi Matsunami and Masaru Okabe. These partnerships have fostered innovation and advancement in their respective fields.
Conclusion
Shuji Miyagawa's contributions to the development of chimeric molecules and modified genes for mammals highlight his role as an influential inventor in biotechnology. His work continues to pave the way for future advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile